
VLNS
Healthcare · Pharmaceuticals · $61.5M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Nov 30, 2022
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 13, 2022 | Before the open | -0.17 | -0.27 | -56.7% |
| Jul 13, 2022 | After the close | -0.19 | -1.68 | -783.5% |
| Apr 13, 2022 | After the close | -0.28 | -0.38 | -35.7% |
| Feb 28, 2022 | After the close | -0.12 | -0.34 | -183.3% |
| Oct 13, 2021 | After the close | — | -0.18 | — |
| Jul 14, 2021 | After the close | — | -0.19 | — |
| Apr 14, 2021 | After the close | — | -0.14 | — |
| Feb 24, 2021 | After the close | — | -0.12 | — |
| Oct 14, 2020 | After the close | -0.09 | -0.06 | +33.3% |
| Jul 15, 2020 | After the close | — | -0.06 | — |
| Apr 15, 2020 | Before the open | 0.21 | 0.06 | -71.4% |
| Feb 24, 2020 | After the close | 0.15 | 0.12 | -20.0% |
| Oct 15, 2019 | After the close | 0.02 | 0.05 | +150.0% |
The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands;…
| Jul 15, 2019 | After the close | -0.02 | -0.01 | +50.0% |
| Apr 24, 2019 | Time not confirmed | -0.01 | -0.06 | -500.0% |
| Mar 13, 2019 | Before the open | -0.01 | -0.06 | -500.0% |
| Feb 28, 2019 | Time not confirmed | — | -0.16 | — |
| Oct 30, 2018 | After the close | — | -0.20 | — |
| Jul 27, 2018 | Before the open | — | -0.07 | — |
| Apr 30, 2018 | Before the open | — | -0.08 | — |
| Feb 4, 2018 | After the close | — | -0.14 | — |